245 related articles for article (PubMed ID: 32971870)
1. Urinary Resveratrol Metabolites Output: Differential Associations with Cardiometabolic Markers and Liver Enzymes in House-Dwelling Subjects Featuring Metabolic Syndrome.
Bullón-Vela V; Abete I; Zulet MA; Xu Y; Martínez-González MA; Sayón-Orea C; Ruiz-Canela M; Toledo E; Sánchez VM; Estruch R; Lamuela-Raventós RM; Almanza-Aguilera E; Fitó M; Salas-Salvadó J; Díaz-López A; Tinahones FJ; Tur JA; Romaguera D; Konieczna J; Pintó X; Daimiel L; Rodriguez-Mateos A; Alfredo Martínez J
Molecules; 2020 Sep; 25(18):. PubMed ID: 32971870
[TBL] [Abstract][Full Text] [Related]
2. Health associations of liver enzymes and inflammatory scores with urinary citrus flavonoid metabolites.
Bullón-Vela V; Xu Y; Razquin C; Abete I; Zulet MA; Martínez-González MA; Buil-Corsiales P; Vitelli-Storelli F; Martín Sánchez V; Vazquez-Ruíz Z; Sayón-Orea C; Domínguez-Fernández M; Cid C; Estruch R; Lamuela-Raventós RM; Fitó M; Blanchart G; Babio N; Salas-Salvadó J; Tinahones FJ; Tur JA; Romaguera D; Konieczna J; Pintó X; Daimiel L; Rodriguez-Mateos A; Martínez JA
Food Funct; 2023 Jan; 14(2):1011-1023. PubMed ID: 36562455
[No Abstract] [Full Text] [Related]
3. The effects of resveratrol on lipid profiles and liver enzymes in patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials.
Akbari M; Tamtaji OR; Lankarani KB; Tabrizi R; Dadgostar E; Haghighat N; Kolahdooz F; Ghaderi A; Mansournia MA; Asemi Z
Lipids Health Dis; 2020 Feb; 19(1):25. PubMed ID: 32066446
[TBL] [Abstract][Full Text] [Related]
4. Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome.
Sogabe M; Okahisa T; Kurihara T; Takehara M; Kagemoto K; Okazaki J; Kida Y; Hirao A; Tanaka H; Tomonari T; Taniguchi T; Okamoto K; Nakasono M; Takayama T
PLoS One; 2020; 15(8):e0238388. PubMed ID: 32866186
[TBL] [Abstract][Full Text] [Related]
5. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
[TBL] [Abstract][Full Text] [Related]
6. Relationship of visceral adipose tissue with surrogate insulin resistance and liver markers in individuals with metabolic syndrome chronic complications.
Bullón-Vela V; Abete I; Tur JA; Konieczna J; Romaguera D; Pintó X; Corbella E; Martínez-González MA; Sayón-Orea C; Toledo E; Corella D; Macías-Gonzalez M; Tinahones FJ; Fitó M; Estruch R; Ros E; Salas-Salvadó J; Daimiel L; Mascaró CM; Zulet MA; Martínez JA
Ther Adv Endocrinol Metab; 2020; 11():2042018820958298. PubMed ID: 33149882
[TBL] [Abstract][Full Text] [Related]
7. Metabolic and genetic markers' associations with elevated levels of alanine aminotransferase in adolescents.
Ramírez-López G; Morán-Villota S; Mendoza-Carrera F; Portilla-de Buen E; Valles-Sánchez V; Castro-Martínez XH; Sánchez-Corona J; Salmerón J
J Pediatr Endocrinol Metab; 2018 Mar; 31(4):407-414. PubMed ID: 29584615
[TBL] [Abstract][Full Text] [Related]
8. Examining dyslipidaemia, metabolic syndrome and liver enzyme levels in patients with prediabetes and type 2 diabetes in population from Hoveyzeh cohort study: A case-control study in Iran.
Dinarvand N; Cheraghian B; Rahimi Z; Salehipour Bavarsad S; Bavarsad A; Mohammadtaghvaei N
Endocrinol Diabetes Metab; 2023 Mar; 6(2):e401. PubMed ID: 36597273
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism.
Stechemesser L; Eder SK; Wagner A; Patsch W; Feldman A; Strasser M; Auer S; Niederseer D; Huber-Schönauer U; Paulweber B; Zandanell S; Ruhaltinger S; Weghuber D; Haschke-Becher E; Grabmer C; Rohde E; Datz C; Felder TK; Aigner E
Mol Metab; 2017 Jan; 6(1):38-47. PubMed ID: 28123936
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus.
Music M; Dervisevic A; Pepic E; Lepara O; Fajkic A; Ascic-Buturovic B; Tuna E
Med Arch; 2015 Aug; 69(4):251-5. PubMed ID: 26543313
[TBL] [Abstract][Full Text] [Related]
11. [Association of abnormality of liver enzymes and metabolic syndrome in patients with nonalcoholic fatty liver disease].
Liu M; Yan HM; Gao X; Gao J
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):253-5. PubMed ID: 17425870
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
[TBL] [Abstract][Full Text] [Related]
13. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
14. Large-scale analysis of factors influencing nonalcoholic fatty liver disease and its relationship with liver enzymes.
Bi WR; Yang CQ; Shi Q; Xu Y; Cao CP; Ling J; Wang XY
Genet Mol Res; 2014 Aug; 13(3):5880-91. PubMed ID: 25117346
[TBL] [Abstract][Full Text] [Related]
15. Increased liver markers are associated with higher risk of type 2 diabetes.
Ko SH; Baeg MK; Han KD; Ko SH; Ahn YB
World J Gastroenterol; 2015 Jun; 21(24):7478-87. PubMed ID: 26139993
[TBL] [Abstract][Full Text] [Related]
16. The associations between liver enzymes and the risk of metabolic syndrome in the elderly.
Liu CF; Zhou WN; Lu Z; Wang XT; Qiu ZH
Exp Gerontol; 2018 Jun; 106():132-136. PubMed ID: 29499373
[TBL] [Abstract][Full Text] [Related]
17. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
[TBL] [Abstract][Full Text] [Related]
18. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
[TBL] [Abstract][Full Text] [Related]
20. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.
Hanley AJ; Williams K; Festa A; Wagenknecht LE; D'Agostino RB; Haffner SM
Diabetes; 2005 Nov; 54(11):3140-7. PubMed ID: 16249437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
